Vor Biopharma picks up $110m Series B
Cambridge, Massachusetts-based Vor Biopharma, an oncology company, has raised $110 million in a Series B financing.
7 July 2020•1 min read
Cambridge, Massachusetts-based Vor Biopharma, an oncology company, has raised $110 million in a Series B financing.
